It is a triple-negative breast cancer cell line that fails to express the human epidermal growth factor receptor 2 (HER2) gene, progesterone receptor (PR), and estrogen receptor (ER) [42]. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.